NYSE · Medical - Instruments & Supplies

Bausch + Lomb Corporation (BLCO) Stock

$17.30 +0.87% NYSE: BLCO Healthcare

Valuation

MetricValue
Price$17.30
Market Cap$6.18B
P/E Ratio-35.85
P/B Ratio0.96
P/S Ratio1.15
EPS (TTM)$0.00
52-Week High$18.92
52-Week Low$13.77
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-2.67%
ROA-1.23%
ROCE3.17%
Gross Margin55.86%
Operating Margin5.91%
Net Margin-3.21%
Debt/Equity0.80
Current Ratio1.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.8B$3.8B$4.1B$4.8B$5.1B
Operating Profit$329.0M$207.0M$130.0M$162.0M$188.0M
Net Profit$182.0M$6.0M$-260.0M$-317.0M$-360.0M
EPS$0.52$0.04$-0.74$-0.90$-1.02
Op Margin8.7%5.5%3.1%3.4%3.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$10.8B$11.1B$13.4B$13.5B$14.0B
Total Liabilities$1.4B$4.0B$6.5B$6.9B$7.5B
Cash$174.0M$380.0M$334.0M$305.0M$383.0M
Borrowings$140.0M$2.6B$4.7B$4.9B$5.4B

Latest News

Bausch + Lomb Launches EyeGility™ Inserter Preloaded IOL Delivery System in the United States Business Wire · Jul 16, 2026 Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others GlobeNewswire · Jul 13, 2026 Why Bausch + Lomb (BLCO) Stock Is Trading Lower Today StockStory · Jul 10, 2026 Sector Update: Healthcare Stocks Decline Late Afternoon MT Newswires · Jul 10, 2026 Sector Update: Healthcare Stocks Decline Friday Afternoon MT Newswires · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$873.0M$345.0M$-17.0M$232.0M$283.0M
Investing Cash Flow$-407.0M$-390.0M$-2.3B$-703.0M$-804.0M
Financing Cash Flow$-740.0M$-2.4B$-37.0M$-23.0M$-24.0M
Net Cash Flow$-61.0M$203.0M$-46.0M$-18.0M$81.0M
Free Cash Flow$680.0M$170.0M$-198.0M$-59.0M$-66.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.44
EV / EBITDA14.65
FCF Yield2.29%
Quick Ratio1.02
Interest Coverage0.96
Return 1Y16.27%
Return 3Y3.19%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Bausch + Lomb Corporation

Bausch + Lomb Corporation (BLCO) stock trades at $17.30 with a market capitalization of $6.18B. The stock is valued at a price-to-earnings (P/E) ratio of -35.85, price-to-book of 0.96, price-to-sales of 1.15. Over the past 52 weeks the stock has ranged between $13.77 and $18.92, and currently trades 8.6% below its 52-week high.

On profitability, Bausch + Lomb Corporation generates a return on equity (ROE) of -2.67%, return on capital employed of 3.17%, an operating margin of 5.91%, a net profit margin of -3.21%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides